Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC

Background & Aims: Antiviral treatment is known to improve survival in patients with chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC). Yet, the treatment uptake in CHB patients remains low. We aimed to report the secular trend in antiviral treatment uptake from 2007–2017, and...

Full description

Bibliographic Details
Main Authors: Vicki Wing-Ki Hui, Stephen Lam Chan, Vincent Wai-Sun Wong, Lilian Yan Liang, Terry Cheuk-Fung Yip, Jimmy Che-To Lai, Becky Wing-Yan Yuen, Hester Wing-Sum Luk, Yee-Kit Tse, Hye-Won Lee, Henry Lik-Yuen Chan, Grace Lai-Hung Wong
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:JHEP Reports
Subjects:
Entecavir
Hazard ratio
Lamivudine
Local ablative therapy
Propensity scores
Surgical resection
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555920300860

Internet

http://www.sciencedirect.com/science/article/pii/S2589555920300860

Similar Items